These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1133 related articles for article (PubMed ID: 29669316)
1. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo. Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316 [TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
4. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072 [TBL] [Abstract][Full Text] [Related]
7. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway. Guo Z; Ye H; Zheng X; Yin W; He J J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway. Han J; Hu J; Sun F; Bian H; Tang B; Fang X Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611 [TBL] [Abstract][Full Text] [Related]
10. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922 [TBL] [Abstract][Full Text] [Related]
11. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1. Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500 [TBL] [Abstract][Full Text] [Related]
12. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Yang WB; Zhang WP; Shi JL; Wang JW Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192 [TBL] [Abstract][Full Text] [Related]
13. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells. Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486 [TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Jin H; Qiao F; Wang Y; Xu Y; Shang Y Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877 [TBL] [Abstract][Full Text] [Related]
15. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer. Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350 [TBL] [Abstract][Full Text] [Related]
18. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Wang C; Li S; Xu J; Niu W; Li S Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720 [TBL] [Abstract][Full Text] [Related]
19. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis. Tang Y; Yan G; Song X; Wu K; Li Z; Yang C; Deng T; Sun Y; Hu X; Yang C; Bai H; Li H; Tan W; Ye M; Liu J J Cell Mol Med; 2015 Dec; 19(12):2806-17. PubMed ID: 26354852 [TBL] [Abstract][Full Text] [Related]
20. Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway. Wu L; Zhang G; Zhu Q; Huang Y J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]